Jennison Associates LLC Neogenomics Inc Transaction History

Jennison Associates LLC

$155 Billion
Q2 2024

A detailed history of Jennison Associates LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Jennison Associates LLC holds 1,219,427 shares of NEO stock, worth $16.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,219,427

Previous 1,051,627 15.96%

Holding current value

$16.5 Million

Previous $16.5 Million 2.31%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$13.01 - $15.77 $2.18 Million - $2.65 Million	167,800 Added 15.96%	1,219,427 $16.9 Million
Q1 2024 May 02, 2024	BUY	$14.06 - $16.79 $6.47 Million - $7.72 Million	460,071 Added 77.77%	1,051,627 $16.5 Million
Q4 2023 Feb 01, 2024	BUY	$11.67 - $20.73 $1.04 Million - $1.85 Million	89,473 Added 17.82%	591,556 $9.57 Million
Q3 2023 Oct 31, 2023	BUY	$12.15 - $17.85 $6.1 Million - $8.96 Million	502,083 New	502,083 $6.18 Million
Q4 2021 Feb 08, 2022	SELL	$30.49 - $48.49 $9.18 Million - $14.6 Million	-301,226 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$41.66 - $52.52 $6.75 Million - $8.51 Million	-162,018 Reduced 34.97%	301,226 $14.5 Million
Q2 2021 Aug 12, 2021	SELL	$36.62 - $51.69 $531,795 - $750,642	-14,522 Reduced 3.04%	463,244 $20.9 Million
Q1 2021 May 11, 2021	SELL	$41.56 - $59.88 $2.6 Million - $3.74 Million	-62,516 Reduced 11.57%	477,766 $23 Million
Q4 2020 Feb 05, 2021	BUY	$36.08 - $56.47 $4.78 Million - $7.48 Million	132,470 Added 32.48%	540,282 $29.1 Million
Q3 2020 Nov 04, 2020	BUY	$33.26 - $40.48 $402,878 - $490,334	12,113 Added 3.06%	407,812 $15 Million
Q2 2020 Aug 06, 2020	BUY	$24.21 - $31.02 $8.85 Million - $11.3 Million	365,352 Added 1203.91%	395,699 $12.3 Million
Q1 2020 May 06, 2020	SELL	$20.5 - $34.53 $203,216 - $342,295	-9,913 Reduced 24.62%	30,347 $838,000
Q2 2019 Aug 06, 2019	BUY	$19.57 - $24.1 $7,456 - $9,182	381 Added 0.96%	40,260 $0
Q1 2019 May 10, 2019	SELL	$12.14 - $20.46 $93,465 - $157,521	-7,699 Reduced 16.18%	39,879 $816,000
Q4 2018 Feb 06, 2019	BUY	$11.24 - $18.5 $49,624 - $81,677	4,415 Added 10.23%	47,578 $600,000
Q3 2018 Nov 08, 2018	SELL	$12.5 - $15.38 $7,162 - $8,812	-573 Reduced 1.31%	43,163 $663,000
Q2 2018 Aug 02, 2018	BUY	$7.99 - $14.05 $55,035 - $96,776	6,888 Added 18.69%	43,736 $573,000
Q1 2018 Apr 20, 2018	BUY	$7.23 - $8.76 $266,411 - $322,788	36,848 New	36,848 $301,000

Others Institutions Holding NEO

# of Institutions

278

Shares Held

127M

Call Options Held

581K

Put Options Held

107K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.71B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Account

Jennison Associates LLC Neogenomics Inc Transaction History